Danaher Corporation vs Expedia Group Inc — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Expedia Group Inc trades at $274.22 (market cap $32.42B). The key difference: Danaher Corporation is far larger — about 4.7× Expedia Group Inc's market cap, and Danaher Corporation pays the higher dividend (0.74%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Expedia Group Inc for 47 Days on average.
| DHR | EXPE | |
|---|---|---|
Market Cap | $152.87B | $32.42B |
Volume | 5,228,698 | 1,940,671 |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $339.13 |
52-Week Low | $161.91 | $188.51 |
Typical Hold Time | 69 Days | 47 Days |
Enterprise Value | $175.08B | $30.98B |
Dividend Yield | 0.74% | 0.71% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
Expedia Group (EXPE) trades at $270.13, up 4.35% with strong technical momentum above key support levels. The company demonstrates robust fundamentals with consistent earnings beats, 90.43% gross margins, and improving cash flow trends. Recent news highlights competitive threats from AI travel agents but also strategic partnerships and positive growth outlook. Analyst consensus remains mixed with a $335.06 price target representing 24% upside potential from current levels.
Expedia presents a compelling value opportunity with reasonable valuation multiples (P/E 16.99, P/S 2.18) and strong profitability metrics. However, investors face significant competitive risks from AI disruption and recent layoffs indicate operational challenges. The stock's upside depends on maintaining booking growth momentum against increasing industry competition and technological disruption.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →